3757 AF1503 pre-HAMP domain
Ligands and drugs
Aggregated over all current member domains of this group. Drug annotations come from DrugDomain; buffers and crystallization additives are excluded from the tables below.
Chemical profile
ClassyFire chemical superclasses of the ligands bound by this X-group's proteins, from DrugDomain annotations.
The raw number of superclasses rises with the number of proteins sampled; the per-20 value compares X-groups at equal depth.
| Superclass | Proteins | Expected | 0.25×observed / expected4× | Ratio | Significance |
|---|---|---|---|---|---|
| Mixed metal/non-metal compounds | 2 | 0.0 | 48× | not tested | |
| Benzenoids | 1 | 0.1 | 6.94× | not tested | |
| Homogeneous non-metal compounds | 2 | 0.4 | 4.71× | not tested | |
| Organic oxygen compounds | 1 | 0.4 | 2.55× | not tested | |
| Homogeneous metal compounds | 1 | 1.0 | 1.03× | not tested |
Unit: a protein (UniProt accession) with a ligand-binding domain in this X-group, counted once per superclass. Expected counts use each superclass's frequency across all ligand-binding X-groups; significance is Fisher's exact test with Benjamini–Hochberg correction. Buffers and crystallization additives are excluded. ECOD v295.2; the method follows the ECOD 2027 update, whose published figures used a slightly different artifact filter.
DrugBank compounds
| DrugBank | PDB ligand | Name | Domains |
|---|---|---|---|
| DB00141 | NAG | N-Acetylglucosamine | 8 |
| DB09353 | PS9 | Octasulfur | 4 |
| DB04445 | HGI | Mercuric iodide | 2 |
Most frequently bound compounds
| PDB ligand | Name | Domains in contact |
|---|---|---|
| NAG | 2-acetamido-2-deoxy-beta-D-glucopyranose | 8 |
| 1KW | ortho-carborane | 4 |
| 8P0 | pyrene | 4 |
| NPY | NAPHTHALENE | 4 |
| PS9 | octathiocane | 4 |
| HGI | MERCURY (II) IODIDE | 3 |
| HGN | mercuriomercury | 3 |
| BEQ | N-(CARBOXYMETHYL)-N,N-DIMETHYL-3-[(1-OXODODECYL)AMINO]-1-PROPANAMINIUM INNER SALT | 2 |
| IOD | IODIDE ION | 2 |
| NAmetal | SODIUM ION | 1 |